Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia

American Journal of Psychiatry

Volumn 165, Issue 12, 2008, Pages 1585-1593

  Lewis, David A ^a   Cho, Raymond Y ^a   Carter, Cameron S ^a   Eklund, Kevin ^a   Forster, Sarah ^a   Kelly, Mary Ann ^a   Montrose, Debra ^a  

^a W1651 Biomedical Science Tower ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A ALPHA2 RECEPTOR; 4 AMINOBUTYRIC ACID A ALPHA3 RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; CYTOCHROME P450 3A4; MK 0777; OLANZAPINE; PLACEBO; RECEPTOR SUBUNIT; RISPERIDONE; UNCLASSIFIED DRUG; ZIPRASIDONE;

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COORDINATION DISORDER; DIZZINESS; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; HEADACHE; HUMAN; INCREASED APPETITE; INSOMNIA; MALE; MEMORY DISORDER; NEUROTRANSMISSION; OSCILLATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA; SOMNOLENCE; WORKING MEMORY; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, GABA-A; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SYNAPTIC TRANSMISSION;

EID: 57349167353     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08030395     Document Type: Article

References (42)

1. Gold JM: Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 2004; 72:21-28
2. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330
3. Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL: Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 1998; 155:1080-1086
4. Hyman SE, Fenton WS: Medicine: What are the right targets for psychopharmacology? Science 2003; 299:350-351
5. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD: Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998; 155:1285-1287
6. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR: Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 2003; 160:2209-2215
7. Manoach DS: Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 2003; 60:285-298
8. Van Snellenberg JX, Torres IJ, Thornton AE: Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 2006; 20:497-510
9. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 2000; 20:485-494
10. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995; 52:258-266
11. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000; 57:237-245
12. 67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2000; 57:1061-1069
13. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA: Relationship of brain-derived neurotrophic factor and its receptor Trkb to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 2005; 25:372-383
14. 67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007; 12:854-869
15. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23:6315-6326
16. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A 1998; 95:5341-5346
17. Volk DW, Pierri JN, Fritschy J-M, Auh S, Sampson AR, Lewis DA: Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002; 12:1063-1070
18. Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6:312-324
19. Whittington MA, Traub RD: Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci 2003; 26:676-682
20. Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, Schulze-Bonhage A, Kahana MJ: Gamma oscillations correlate with working memory load in humans. Cereb Cortex 2003; 13:1369-1374
21. Cho RY, Konecky RO, Carter CS: Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A 2006; 103:19878-19883
22. Lewis DA, Volk DW, Hashimoto T: Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 2004; 174:143-150
23. (2, 3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol 2007; 21:374-383
24. Gold JM, Queern C, Iannone VN, Buchanan RW: Repeatable Battery for the Assessment of Neuropsychological Status as a screening test in schizophrenia, I: sensitivity, reliability, and validity. Am J Psychiatry 1999; 156:1944-1950
25. A receptor α1 subtype. Nat Neurosci 2000; 3:587-592
26. Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, Buchanan RW: Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. Am J Psychiatry 2002; 159:838-844
27. Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M: A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 2001; 158:2071-2074
28. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, Smith EE: Temporal dynamics of brain activation during a working memory task. Nature 1997; 386:604-608
29. Perlstein WM, Carter CS, Noll DC, Cohen JD: Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 2001; 158:1105-1113
30. Cohen JD, Barch DM, Carter C, Servan-Schreiber D: Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J Abnorm Psychol 1999; 108:120-133
31. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DC, Cohen JD: Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 2001; 58:280-288
32. Barch DM, Carter CS, MacDonald AW III, Braver TS, Cohen JD: Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms. J Abnorm Psychol 2003; 112:132-143
33. Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC, Woerner MG, Schooler NR, Kane JM, Robinson DG: Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: Is it a practice effect? Arch Gen Psychiatry 2007; 64:1115-1122
34. Carter CS: Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophr Bull 2005; 31:810-815
35. Harvey PD, Green MF, McGurk SR, Meltzer HY: Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study. Psychopharmacology (Berl) 2003; 169:404-411
36. Overstreet LS, Westbrook GL: Synapse density regulates independence at unitary inhibitory synapses. J Neurosci 2003; 23:2618-2626
37. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J: Induced gamma-band activity during the delay of a visual short-term memory task in humans. J Neurosci 1998; 18:4244-4254
38. Compte A, Brunel N, Goldman-Rakic PS, Wang XJ: Synaptic mechanisms and network dynamics underlying spatial working memory in a cortical network model. Cereb Cortex 2000; 10:910-923
39. Camperi M, Wang XJ: A model of visuospatial working memory in prefrontal cortex: recurrent network and cellular bistability. J Comput Neurosci 1998; 5:383-405
40. Traub RD, Bibbig A, LeBeau FE, Cunningham MO, Whittington MA: Persistent gamma oscillations in superficial layers of rat auditory neocortex: experiment and model. J Physiol 2005; 562(pt 1):3-8
41. Kopell N, Ermentrout GB, Whittington MA, Traub RD: Gamma rhythms and beta rhythms have different synchronization properties. Proc Natl Acad Sci U S A 2000; 97:1867-1872
42. Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, Fritschy J-M, Rülicke T, Bluethmann H, Möhler H, Rudolph U: Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000; 290:131-134